Get started
Author

Catherine Nabaggala

Institution: Makerere University
ORCID: 0009-0008-5520-5683
Observed ORCID: 0009-0008-5520-5683
OpenAlex ID: A5089640570
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
2020 · Chandy C. John, Robert O. Opoka, et al. · New England Journal of Medicine · 152
PDF
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens
2023 · David Teigen, Robert O. Opoka, et al. · PharmacoEconomics · 13
PDF
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
2024 · Vincent Mboizi, Catherine Nabaggala, et al. · Contemporary Clinical Trials Communications · 6
Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
2025 · Shubaya K. Naggayi, Dennis Kalibbala, et al. · Blood Advances · 5
Orbital compression syndrome in a Ugandan child with sickle cell disease: A case report
2021 · Ronald Olum, Catherine Nabaggala, et al. · Clinical Case Reports · 5
PDF
Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls
2025 · Dennis Kalibbala, Vincent Mboizi, et al. · British Journal of Haematology · 3
Other-05 the Challenges in Managing Children With Primary Central Nervous System Tumors in Uganda
2023 · Victoria Katasi, Ronald Naitala, et al. · Neuro-Oncology Advances · 1
PDF
Acute soft head syndrome and orbital compression syndrome in a child with sickle cell disease: a case report
2025 · David Mukunya, Catherine Nabaggala, et al. · Journal of Medical Case Reports
Overview of Organ Dysfunction in Sickle Cell Disease
2024 · Ruth Namazzi, Catherine Nabaggala, et al. · Routledge eBooks
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (Brain Safe Ii): Protocol for a Single-Arm Open Label Trial
2024 · Richard Idro, Vincent Mboizi, et al. · SSRN Electronic Journal
Effect of Hydroxyurea Treatment on Body Composition in Children with Sickle Cell Anemia in Uganda Using Bioelectrical Impedance Analysis (BIA)
2023 · Dennis Kalibala, Catherine Nabaggala, et al. · Blood
PDF
Malaria in Children with Sickle Cell Anaemia in Areas with Low, Moderate and High Transmission in Uganda
2023 · Ruth Namazzi, Richard Idro, et al. · Blood
132:poster Cost-effectiveness of using hydroxyurea to treat sickle cell anemiain uganda: a model-based comparison of two dosing regimens
2022 · David Teigen, Robert O Opoka, et al. · Abstracts
PDF
Works count: 13
Citation count: 185
H-index: 5
I10-index: 2
Year
Topic
Type